The chemical-biological interface: developments in automated and miniaturised screening technology

Area of Science:

• Drug discovery and development
• Chemical biology
• Genomics and proteomics

Background:

• Genomics and combinatorial chemistry generate numerous drug targets and compounds.
• High-throughput screening (HTS) technologies have been revolutionized by these advancements.
• Robotics, automation, and novel biological assay technologies are key drivers.

Purpose of the Study:

• To highlight the impact of technological advancements on HTS.
• To emphasize the growing importance of miniaturization in HTS and combinatorial chemistry.
• To discuss the integration of automation and new assay technologies in modern drug discovery.

Main Methods:

• Introduction of robotics and automation in screening processes.
• Development and implementation of new biological assay technologies, such as homogeneous time-resolved fluorescence.
• Adoption of miniaturization techniques, including high-density microtitre plates and small-volume liquid handling robots.

Main Results:

• Significant improvements in the efficiency and capacity of drug screening.
• Enabling the analysis of larger compound libraries and identification of novel drug targets.
• Demonstration of miniaturization's critical role in managing increasing workloads and constraints.

Conclusions:

• Miniaturization is indispensable for the future of high-throughput screening and combinatorial chemistry.
• Technological integration, including automation and advanced assays, is crucial for efficient drug discovery.
• The field is rapidly evolving to meet the demands of large-scale compound and target analysis.